Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone : Analysis of the Austrian head and neck cancer registry of the AGMT.

Research output: Contribution to journalOriginal Articlepeer-review

4 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1136
JournalWIENER KLINISCHE WOCHENSCHRIFT
Volume133
Issue number21-22
DOIs
Publication statusPublished - 2021

Keywords

  • LOCALLY-ADVANCED HEAD
  • SQUAMOUS-CELL CARCINOMA
  • CONCURRENT RADIOTHERAPY
  • RADIATION-THERAPY
  • CHEMOTHERAPY
  • RISK

Cite this